Zobrazeno 1 - 10
of 149
pro vyhledávání: '"Yubing ZHOU"'
Autor:
Sihan Liu, Jiadi Gao, Hanshu Zhao, Yuanqi Xu, Yubing Zhou, Yushuang Liu, Jinru Shen, Zhongling Zhang
Publikováno v:
SAGE Open Medicine, Vol 12 (2024)
Background: The relationship between blood pressure variability and hemorrhagic transformation after recombinant tissue plasminogen activator thrombolysis in patients with acute ischemic stroke is uncertain due to inconsistent methodologies across st
Externí odkaz:
https://doaj.org/article/7d819a98d0074237b36239a6ed022203
Publikováno v:
大数据, Vol 10, Pp 122-139 (2024)
Unbalanced medical and educational resources, low intelligence of the medical system, and reliance on individual experience in surgical operations are common in medical trade.The metaverse with immersive and interactive features is an effective tool
Externí odkaz:
https://doaj.org/article/01c19fe2c6004cbca649a81055c27155
Publikováno v:
Translational Oncology, Vol 44, Iss , Pp 101945- (2024)
Metformin, as the preferred antihyperglycemic drug for type 2 diabetes, has been found to have a significant effect in inhibiting tumor growth in recent years. However, metformin alone in cancer treatment has the disadvantages of high dose concentrat
Externí odkaz:
https://doaj.org/article/4fe67bf6f4ed4aeeb5f43d30338e837e
Autor:
Xinru Wang, Rumeng Ding, Zhe Fu, Meng Yang, Duolu Li, Yubing Zhou, Chongzhen Qin, Wenda Zhang, Liuzhe Si, Jingmin Zhang, Yuna Chai
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background and objective: Osteosarcoma is a common primary malignant tumor of bone, and doxorubicin is one of the most widely used therapeutic drugs. While the problem of doxorubicin resistance limits the long-term treatment benefits in osteosarcoma
Externí odkaz:
https://doaj.org/article/79f9c6924f4c4ff7880219e632d0adba
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Inter-individual differences of drug responses could be attributed to genetic variants of pharmacogenes such as cytochrome P450 (CYP), phase 2 enzymes, and transporters. In contrast to extensive studies on the genetic polymorphisms of CYP ge
Externí odkaz:
https://doaj.org/article/8aaecce1c52a46daa08aede5d1ff68f8
Publikováno v:
ACS Omega, Vol 5, Iss 35, Pp 22674-22681 (2020)
Externí odkaz:
https://doaj.org/article/b9964940a50545c48ed3587bbac215aa
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background The well-known traditional Chinese herbal formula Guizhi Fuling Wan (GFW) was recently reported to improve the curative effects of chemotherapy for ovarian cancer with few clinical side effects. The present study aimed to investig
Externí odkaz:
https://doaj.org/article/451376da2bf54c52b292abd82ecea1ce
Autor:
Jianhao Li, Weiwei Wang, Yubing Zhou, Liwen Liu, Guizhen Zhang, Kelei Guan, Xichun Cui, Xin Liu, Maoxin Huang, Guangying Cui, Ranran Sun
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Background: Immunotherapy elicits durable responses in many tumors. Nevertheless, the positive response to immunotherapy always depends on the dynamic interactions between the tumor cells and infiltrating lymphocytes in the tumor microenvironment (TM
Externí odkaz:
https://doaj.org/article/23b826c5a7fe4e08a81ba4c2de8a76d4
Publikováno v:
ACS Omega, Vol 4, Iss 1, Pp 546-554 (2019)
Externí odkaz:
https://doaj.org/article/c653446f44ba4890b902feb26fe11dfe
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Isocitrate dehydrogenase (IDH) is a key metabolic enzyme catalyzing the interconversion of isocitrate to α-ketoglutarate (α-KG). Mutations in IDH lead to loss of normal enzymatic activity and gain of neomorphic activity that irreversibly converts
Externí odkaz:
https://doaj.org/article/8dcefe4504b74aefa1c86c70c05838a3